跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 58,219 条关于
“Fate Therapeutics, Inc.”
全部
58,219
临床试验
20,816
药物
4,538
机构
6,565
资讯
26,300
10个月前
Fate Therapeutics Advances Two Phase 1 CAR-T Cell Therapy Studies for Advanced Solid Tumors
去年
Fate Therapeutics Shifts Focus to Autoimmune Diseases with Promising Cell Therapies
3个月前
Vir Biotechnology Appoints Timothy Coughlin to Board of Directors Amid Pipeline Advancement
去年
Fate Therapeutics to Showcase Innovative Off-the-Shelf CAR T-Cell Platform at ASGCT Annual Meeting
6个月前
NexImmune Advances NEX-ILE12 Immunotherapy in Phase 1 Trials with Promising Safety Profile
去年
CRISPR Gene Editing Advances CAR-NK Cell Therapy to Overcome Clinical Bottlenecks
去年
Fate Therapeutics Presents Promising Early Data for FT825/ONO-8250 CAR-T Therapy in Solid Tumors
去年
Fate Therapeutics' FT825 Shows Promise in HER2-Targeting CAR T-Cell Therapy for Solid Tumors
10个月前
Fate Therapeutics Reports Promising Phase 1 Data for Off-the-Shelf CAR-T Therapy in Lupus
2年前
Fate Therapeutics Treats First Lupus Patient with Off-the-Shelf CAR-T Cell Therapy FT819
第 1 页,共 2630 页
上一页
下一页